slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
82,5 TWD | -2,71% | -4,95% | +0,61% |
Vakgebied
Verkoop per activiteit
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Monoclonal Antibodies
100,0
%
| 563 | 100,0 % | 492 | 100,0 % | -12,65% |
Verkoop per regio
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Taiwan
100,0
%
| 563 | 100,0 % | 492 | 100,0 % | -12,65% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chin-Ming Chang
CEO | Chief Executive Officer | - | - |
I Cheng Chen
DFI | Director of Finance/CFO | - | 01-06-08 |
Nien Yuan Chang
CHM | Chairman | - | 12-06-09 |
YingAn Lai
LAW | General Counsel | - | - |
Jason Mao
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chi-Chuan Chen
BRD | Director/Board Member | 66 | - |
Ta Meng Tseng
BRD | Director/Board Member | 66 | 07-09-18 |
Nien Yuan Chang
CHM | Chairman | - | 12-06-09 |
Howard Lee
BRD | Director/Board Member | 62 | 26-05-17 |
Tien Chieh Li
BRD | Director/Board Member | - | 24-02-21 |
Shih Chia Lin
BRD | Director/Board Member | - | - |
Gwo-Fong Lin
BRD | Director/Board Member | 68 | 04-06-20 |
Chin Ting Chiu
BRD | Director/Board Member | - | - |
Hui Chuan Chang
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 253 009 730 | 166 588 730 ( 65,84 %) | 0 | 65,84 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,61% | 640 mln. | |
-2,26% | 103 mld. | |
+1,41% | 95,71 mld. | |
+0,79% | 22,02 mld. | |
-17,84% | 20,9 mld. | |
-11,11% | 17,85 mld. | |
-42,83% | 16,21 mld. | |
-17,63% | 15,52 mld. | |
+4,55% | 13,86 mld. | |
+32,11% | 12,04 mld. |
- Beurs
- Aandelen
- Koers 4147
- Onderneming TaiMed Biologics Inc.